The global paracetamol IV market size was USD 797.08 million in 2024, estimated at USD 823.78 million in 2025, and is expected to reach around USD 1,117.85 million by 2034, expanding at a CAGR of ...

Paracetamol IV Market size was valued at USD 860.7 million in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2034. Paracetamol IV, known for its strong ...

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Paracetamol IV Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel ...

The shortage of intravenous (IV) paracetamol is expected to continue until at least November. A Department for Health and Social Care spokesman said it was due to “capacity constraints with a ...

Maxigesic® IV is a unique combination of 1000mg paracetamol with 300mg ibuprofen solution for infusion for use post-operatively. Results from a randomised, double-blind, placebo-controlled Phase ...

Intravenous usage of paracetamol is executed in terminally ill patients, post-surgical patients, and pediatric patients who require instant pain treatment. The usage of intravenous paracetamol has ...

Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Paracetamol IV Market Research Report by Indication (Pain and Pyrexia/Fever), Application, End-use, Region - Cumulative Impact of COVID-19, Russia ...

Hospitals in England face critically low levels of paracetamol amid a national shortage of the painkiller. Paracetamol injections are seen as the safest and most effective drug to give patients to ...